£76.42

Springer Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£77.75 £76.29 £76.61 £76.93 £77.24 £77.56 £77.88 09 July 2026 26 July 2026 12 August 2026 29 August 2026 15 September 2026

Price Distribution

Price distribution over 69 days • 2 price levels

Days at Price
Current Price
52 days · current 17 days 0 13 26 39 52 £76 £78 Days at Price

Price Analysis

Most common price: £76 (52 days, 75.4%)

Price range: £76 - £78

Price levels: 2 different prices over 69 days

Description

The management of advanced renal cell carcinoma is still problematic. Surgery, although the therapy of choice for locally advanced renal tumors, is still controversial as the treatment for metastases. The role of surgery in the management of patients with pulmonary, bony, and liver metastasis is one of the subject matters discussed in this book. Our results with series of patients undergoing resection of metastases from the lung, bone, and liver show that surgery may be appropriate in selected patients with a good performance status, although most of them certainly cannot be cured by this procedure alone, i.e., in the absence of effective adjuvant therapies. As recent developments show, new strategies for immunotherapy of renal cell carcinoma represent a modest advance over traditional approaches in the treatment of this cancer, such as chemo- and radiotherapy. Clinical trials employing recombinant interferon-a and interleukin 2 produced response rates in up to 30% of patients treated, as evidenced by the European Immunotherapy Trials Program. The adverse reactions and the lack of efficacy in the majority of patients warrants the search for new immunotherapeutic approaches.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 December 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)
84% match

Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)

Elsevier

£69.11 13 Sep 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
83% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.76 06 Aug 2026
Therapeutic Strategies in Primary and Metastatic Liver Cancer: 100 (Recent Results in Cancer Research, 100)
83% match

Therapeutic Strategies in Primary and Metastatic Liver Cancer: 100 (Recent Results in Cancer Research, 100)

Springer

£76.42 15 Sep 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
83% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.01 10 Aug 2026
Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)
82% match

Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)

Springer

£88.21 08 Aug 2026
Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)
82% match

Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)

Humana

£103.27 07 Aug 2026
Multimodal Treatment of Recurrent Pelvic Colorectal Cancer (Updates in Surgery)
82% match

Multimodal Treatment of Recurrent Pelvic Colorectal Cancer (Updates in Surgery)

Springer

£85.91 31 Aug 2026
Immunotherapy for Gastrointestinal Cancer
82% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.11 08 Aug 2026
Renal Cancer: Contemporary Management
82% match

Renal Cancer: Contemporary Management

Springer

£103.26 02 Sep 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
82% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 05 Aug 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.55 07 Aug 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
82% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£88.00 13 Aug 2026
Carcinoma of the Prostate: Innovations in Management (Medical Radiology)
81% match

Carcinoma of the Prostate: Innovations in Management (Medical Radiology)

Springer

£77.49 13 Aug 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
81% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.65 05 Aug 2026
Modern Management of Cancer of the Rectum
81% match

Modern Management of Cancer of the Rectum

Springer

£72.71 29 Aug 2026
Robotic Renal Surgery: Benign and Cancer Surgery for the Kidneys and Ureters
81% match

Robotic Renal Surgery: Benign and Cancer Surgery for the Kidneys and Ureters

Springer

£61.84 06 Aug 2026
Liver Metastases
81% match

Liver Metastases

Springer

£80.67 08 Aug 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
81% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£112.42 13 Sep 2026
Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)
81% match

Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)

Springer

£100.98 13 Aug 2026
Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)
81% match

Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)

Springer

£86.27 08 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
81% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
81% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£103.27 18 Aug 2026
Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20)
81% match

Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20)

Springer

£128.00 24 Aug 2026
Molecular Targeted Therapy of Lung Cancer
81% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026